Multifunctional nanomicelles constructed by aggregation and de-aggregation strategy for magnetic resonance/NIR II fluorescence imaging guided Type I photodynamic therapy

08 February 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Fluorescence and magnetic resonance imaging (FL/MRI) has received much attention from their complementary characteristics. However, the simultaneous enhancement of fluorescence and MR signals plus the efficacy of the treatment is still a major challenge. To solve this problem, we put forward a strategy of aggregation and de-aggregation based on aggregation-induced emission (AIE). NIR II photosensitizer TQ-TPA with Type I reactive oxygen species (ROS) generation ability and an amphiphilic 2TPE-Gd were firstly synthesized, and both of them showed the AIE property. Depending on the hydrophilic properties, hydrophobic TQ-TPA spontaneously aggregated into the core of nanomicelles formed by DSPE-PEG. Meanwhile, the aggregated 2TPE-Gd in aqueous solution could de-aggregate and insert in the interface, and formed TGdTT NMs. Based on this strategy and AIE property, TGdTT NMs exhibited strong NIR II fluorescence emission and Type I ROS generation ability, and enhanced T1 relaxivity (r1). Moreover, in vitro, in vivo, and pharmacokinetics results demonstrated these nanomicelles had good biosafety and long blood circulation time. Finally, they successfully realized complementary MR/NIR II fluorescence dual-modal imaging guided photodynamic therapy (PDT) to inhibit tumor growth. This work demonstrated that aggregation and de-aggregation strategy of AIEgens in the core-shell nanomicelle exudes infinite charm for constructing the multifunctional theranostic probes.

Supplementary materials

Title
Description
Actions
Title
The supporting infomation
Description
The supporting information of the manuscript
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.